Evolution of Fatigue in Patients With Inflammatory Bowel Disease
Panoramica dello studio
Stato
Descrizione dettagliata
Fatigue is a common symptom in inflammatory bowel disease and persists despite clinical remission. Fatigue in patients with chronic diseases can be objectified by the FACIT-F scale.
Recent publications have tried to assess the prevalence and factors related to fatigue in patients with IBD.
In 2017 one study evaluated the prevalence and predictive factors of fatigue in out-patients with inflammatory bowel disease. Fatigue was associated with depression, low quality of life and female sex. No association was found with micronutrients or levels of interleukins.
As there are no effective treatments for fatigue in IBD, another study, recently published a study evaluating the role of electroacupuncture in 54 patients with quiescent IBD and fatigue, observing that both electroacupuncture and sham acupuncture improved fatigue compared to the control group.
The aim of this study is to evaluate the evolution and possible factors associated with the persistence of fatigue in patients with quiescent IBD and fatigue included in the two previous studies.
Patients with inflammatory bowel disease and fatigue (FACIT-F score < 40) included in these two previous studies who agree to participate will fill in questionnaires to assess fatigue, anxiety, depression and quality of life in inflammatory bowel disease. Moreover, the relationship of other biological factors with IBD-related fatigue will be determined.
Tipo di studio
Iscrizione (Anticipato)
Contatti e Sedi
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion Criteria:
- Patients with inflammatory bowel disease and fatigue (defined as a FACIT-F score <40 points) previously documented in our two previous studies.
- Written informed consent after receiving clear and objective information about the purpose and characteristics of the study.
- Ability to understand the questionnaires.
Exclusion Criteria:
- Associated tumor disease.
- Pregnancy or breastfeeding.
- Anemia (hemoglobin <12g/dl in women and 14g/dl in men)
- Any concomitant illness that may justify the presence of fatigue.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Coorti e interventi
Gruppo / Coorte |
|---|
|
Patients with Inflammatory Bowel Disease and fatigue
Patients with Inflammatory Bowel Disease and fatigue that participated in the two studies (1,2).
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Evaluate the evolution of fatigue in patients with Inflammatory Bowel Disease at 3 years
Lasso di tempo: three years
|
Assessed by the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F scale).
This questionnaire, previously validated in Spanish and for IBD patients, comprises 40 items divided into five subscales: Physical wellbeing (PWB), Social/family wellbeing (SWB), Emotional wellbeing (EWB), Functional Wellbeing (FWB), and Fatigue subscale.
The first four subscales (27 items) evaluate general features of chronic illness, and the 13 items of the Fatigue subscale specifically focus on fatigue.
Each item has five possible answers, from 0 (very fatigued) to 4 (not at all fatigued).
The score of each subscale is the sum of the coded values of its items.
|
three years
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Assess the biological factors associated with the persistence of fatigue
Lasso di tempo: three years
|
Assessed by a blood test including micronutrients (vitamin B12, ferritin and vitamin D).
|
three years
|
|
Assess the psychological factors associated with the persistence of fatigue
Lasso di tempo: three years
|
Assessed by the Beck Depression Inventory (BDI) questionnaire.
The Spanish validated 21-item version of the BDI will be used to analyze depression.
This self-administered questionnaire evaluates the clinical features of melancholy and intrusive thoughts present in depression.
Each item has a different number of options (from 4 to 8), which then have to be converted into four possible values (0, 1, 2, or 3).
Higher BDI scores indicate a higher grade of depression.
|
three years
|
|
Assess the psychological factors associated with the persistence of fatigue
Lasso di tempo: three years
|
Assessed by Quality of life in inflammatory bowel disease questionnaire (IBDQ-9).
he IBDQ-9 consists of nine items assessing different aspects of life in IBD patients.
Each item has seven different possible answers, scoring from 1 (poorest) to 7 (best).
The straight summation of all nine items provides a direct score, which is then transformed into a final score.
Higher scores correspond to a better quality of life.
|
three years
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Diana Horta, Parc Tauli Hospital. Sabadell , Barcelona, Spain, 08208
Pubblicazioni e link utili
Pubblicazioni generali
- Villoria A, Garcia V, Dosal A, Moreno L, Montserrat A, Figuerola A, Horta D, Calvet X, Ramirez-Lazaro MJ. Fatigue in out-patients with inflammatory bowel disease: Prevalence and predictive factors. PLoS One. 2017 Jul 27;12(7):e0181435. doi: 10.1371/journal.pone.0181435. eCollection 2017.
- Horta D, Lira A, Sanchez-Lloansi M, Villoria A, Teggiachi M, Garcia-Rojo D, Garcia-Molina S, Figuerola A, Esteve M, Calvet X. A Prospective Pilot Randomized Study: Electroacupuncture vs. Sham Procedure for the Treatment of Fatigue in Patients With Quiescent Inflammatory Bowel Disease. Inflamm Bowel Dis. 2020 Feb 11;26(3):484-492. doi: 10.1093/ibd/izz091.
Studiare le date dei record
Studia le date principali
Inizio studio (Anticipato)
Completamento primario (Anticipato)
Completamento dello studio (Anticipato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- HMT3
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .